H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy

Double-strand breaks (DSBs) are the most deleterious DNA lesions, which, if left unrepaired, may have severe consequences for cell survival, as they lead to chromosome aberrations, genomic instability, or cell death. Various physical, chemical, and biological factors are involved in DSB induction....

Full description

Saved in:
Bibliographic Details
Main Authors: Monika Podhorecka, Andrzej Skladanowski, Przemyslaw Bozko
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Journal of Nucleic Acids
Online Access:http://dx.doi.org/10.4061/2010/920161
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565395944374272
author Monika Podhorecka
Andrzej Skladanowski
Przemyslaw Bozko
author_facet Monika Podhorecka
Andrzej Skladanowski
Przemyslaw Bozko
author_sort Monika Podhorecka
collection DOAJ
description Double-strand breaks (DSBs) are the most deleterious DNA lesions, which, if left unrepaired, may have severe consequences for cell survival, as they lead to chromosome aberrations, genomic instability, or cell death. Various physical, chemical, and biological factors are involved in DSB induction. Cells respond to DNA damage by activating the so-called DNA damage response (DDR), a complex molecular mechanism developed to detect and repair DNA damage. The formation of DSBs triggers activation of many factors, including phosphorylation of the histone variant H2AX, producing γH2AX. Phosphorylation of H2AX plays a key role in DDR and is required for the assembly of DNA repair proteins at the sites containing damaged chromatin as well as for activation of checkpoints proteins which arrest the cell cycle progression. In general, analysis of γH2AX expression can be used to detect the genotoxic effect of different toxic substances. When applied to clinical samples from cancer patients, evaluation of γH2AX levels may allow not only to monitor the efficiency of anticancer treatment but also to predict of tumor cell sensitivity to DNA damaging anticancer agents and toxicity of anticancer treatment toward normal cells.
format Article
id doaj-art-8a38a3f830eb48ccaa450481dd63e123
institution Kabale University
issn 2090-021X
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Journal of Nucleic Acids
spelling doaj-art-8a38a3f830eb48ccaa450481dd63e1232025-02-03T01:07:50ZengWileyJournal of Nucleic Acids2090-021X2010-01-01201010.4061/2010/920161920161H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer TherapyMonika Podhorecka0Andrzej Skladanowski1Przemyslaw Bozko2Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20081 Lublin, PolandLaboratory of Molecular and Cellular Pharmacology, Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, 80233 Gdansk, PolandInstitute of Experimental Internal Medicine, Medical Faculty, Otto von Guericke University, 39120 Magdeburg, GermanyDouble-strand breaks (DSBs) are the most deleterious DNA lesions, which, if left unrepaired, may have severe consequences for cell survival, as they lead to chromosome aberrations, genomic instability, or cell death. Various physical, chemical, and biological factors are involved in DSB induction. Cells respond to DNA damage by activating the so-called DNA damage response (DDR), a complex molecular mechanism developed to detect and repair DNA damage. The formation of DSBs triggers activation of many factors, including phosphorylation of the histone variant H2AX, producing γH2AX. Phosphorylation of H2AX plays a key role in DDR and is required for the assembly of DNA repair proteins at the sites containing damaged chromatin as well as for activation of checkpoints proteins which arrest the cell cycle progression. In general, analysis of γH2AX expression can be used to detect the genotoxic effect of different toxic substances. When applied to clinical samples from cancer patients, evaluation of γH2AX levels may allow not only to monitor the efficiency of anticancer treatment but also to predict of tumor cell sensitivity to DNA damaging anticancer agents and toxicity of anticancer treatment toward normal cells.http://dx.doi.org/10.4061/2010/920161
spellingShingle Monika Podhorecka
Andrzej Skladanowski
Przemyslaw Bozko
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Journal of Nucleic Acids
title H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
title_full H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
title_fullStr H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
title_full_unstemmed H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
title_short H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
title_sort h2ax phosphorylation its role in dna damage response and cancer therapy
url http://dx.doi.org/10.4061/2010/920161
work_keys_str_mv AT monikapodhorecka h2axphosphorylationitsroleindnadamageresponseandcancertherapy
AT andrzejskladanowski h2axphosphorylationitsroleindnadamageresponseandcancertherapy
AT przemyslawbozko h2axphosphorylationitsroleindnadamageresponseandcancertherapy